ClinicalTrials.gg
Biological

2019-nCoV Vaccine mRNA-1273 clinical trials

Also written mRNA-1273.

Its developmentBy 4 companies, company by company20 company-led studies, furthest phase 4: when each phase was reached, its deals, target and what is ahead.
studies test it
41
open now
3
in phase 3
14
first study started
2020

How each study uses 2019-nCoV Vaccine mRNA-1273 is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the 2019-nCoV Vaccine mRNA-1273 studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
Not in FDA's approval records
European Union
Not in EMA's list of EU-wide authorizations

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Moderna COVID-19 Vaccine
8
SPIKEVAX®
3
Moderna
3
mRNA-1273 (Moderna COVID-19 vaccine)
2
mRNA-1273 Vaccine
2

Development codes

mRNA-1273
22
TAK-919
1

Other names

Elasomeran
1

Studies by the year they started

41 studies that test it; most in 2021 (23)

Studies that test 2019-nCoV Vaccine mRNA-1273, by start year
YearStudies
20204
202123
20228
20243
20252
20261

By phase

A phase 1/2 study counts in both.

Phase 1
8
Phase 2
18
Phase 3
14
Phase 4
8
No phase
2

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 14 · Other 27

ModernaTX, Inc. (12) · National Institute of Allergy and Infectious Diseases (NIAID) (7) · Murdoch Childrens Research Institute (3) · University Medical Center Groningen (2) · Assistance Publique - Hôpitaux de Paris (2) · Sheba Medical Center (1) · Tor Biering-Sørensen (1) · Merck Sharp & Dohme LLC (1)

Often tested with

Tested in the same studies.

BNT162 Vaccine (12) · MRNA-1283 (3) · mRNA-1010 influenza vaccine (2) · Elasomeran/Davesomeran (2) · Ad26COVS1 (2) · ChAdOx1 nCoV-19 (2) · mRNA-1345 respiratory syncytial virus vaccine (1) · mRNA-1647 cytomegalovirus vaccine (1)

Coming up

From the study records. Dates are the sponsors’ own estimates and often move.

Reaching primary completion within a year · 3

Studies that test 2019-nCoV Vaccine mRNA-1273.

Studies

Open first, then newest update. How each study uses 2019-nCoV Vaccine mRNA-1273 is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 41

See all 41 studies that test 2019-nCoV Vaccine mRNA-1273 →

Given beside what is tested · 6 — 2019-nCoV Vaccine mRNA-1273 is usual care or a partner of the new treatment
As the comparator · 8 — what is tested is compared with 2019-nCoV Vaccine mRNA-1273

What changed recently

From the registry's own updates since Oct 19, 2026.

Codes

What other systems call 2019-nCoV Vaccine mRNA-1273 · ClinicalTrials.gg INT006858

  • MeSH (NLM) D0000909832019-nCoV Vaccine mRNA-1273Confirmed ClinicalTrials.gov, NLM
  • UNII (FDA) EPK39PL4R4ELASOMERANConfirmed FDA, NLM

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.